Z. Szabo et al., POSITRON EMISSION TOMOGRAPHY OF 5-HT TRANSPORTER SITES IN THE BABOON BRAIN WITH [C-11] MCN5652, Journal of cerebral blood flow and metabolism, 15(5), 1995, pp. 798-805
[C-11]McN5652 is a new radioligand specific for 5-hydroxytryptamine (5
-HT; serotonin) transporters. In this study we used [C-11]McN5652 to i
mage the 5-HT transporter sites in baboon brain by positron emission t
omography (PET). Dynamic PET studies were performed in three Papio anu
bis baboons. The animals were injected intravenously first with C-11-l
abeled (+)-McN5652([C-11](+)McN5652), then with pharmacologically inac
tive enantiomer C-11-labeled (-)-McN5652 ([C-11](-)McN5652); two anima
ls received a third study with [C-11](+)McN5652 after pretreatment wit
h the specific 5-HT uptake site inhibitor fluoxetine (5 mg/kg). Initia
l uptake into the brain was similar for both [C-11](+)McN5652 and [C-1
1](-)McN5652. At later times (45-120 min after injection), only [C-11]
(+)McN5652 showed a distribution characteristic for 5-HT uptake sites.
in contrast, in studies with [C-11](-)McN5652 and in those with [C-11
](+)McN5652 after 5-HT uptake site blockade with fluoxetine, C-11 radi
oactivity concentrations were significantly lower and the distribution
pattern was relatively even. The differences between [C-11](+)- and (
-)McN5652 were calculated for the time interval 95-125 min postinjecti
on and used to estimate specific binding. Specific binding correlated
well (r = 0.95, p < 0.001) with the known density of 5-HT uptake sites
in human brain. These results indicate that [C-11](+)McN5652 is suita
ble for PET imaging of 5-HT uptake sites in primate brain.